Search

everythinglearnresearchcommunity

for

Search:↓

Raltegravir may cause hair loss in some patients.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

Bridging anticoagulation may raise post-surgery bleeding risks.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

A scalp blood vessel issue from hair transplant was successfully treated with a special liquid agent.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

The combination treatment showed a higher response rate but no significant survival benefits.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Combined therapy is highly effective for treating diffuse alopecia.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.